Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No substantive changes were detected; updates appear administrative. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:25:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T10:24:37.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated the revision from v3.0.2 to v3.1.0; no other content changes observed.
    Difference
    0.1%
    Check dated 2025-09-28T03:20:21.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-13T17:38:45.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v3.0.1) and includes the latest update date of September 3, 2025, while removing older dates and the previous version (v3.0.0).
    Difference
    0.6%
    Check dated 2025-09-06T15:24:26.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has been updated to include a new facility name and location, along with the addition of specific medical terms related to neuroendocrine neoplasms and treatments. The previous version's details about state, country, and various medical terms have been removed.
    Difference
    1%
    Check dated 2025-08-30T12:06:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.